Instituto Cardiovascular Lezica, Buenos Aires, Argentina.
Instituto Cardiovascular Lezica, Buenos Aires, Argentina.
Vaccine. 2023 Feb 17;41(8):1524-1528. doi: 10.1016/j.vaccine.2023.01.052. Epub 2023 Jan 27.
After the acute infection, COVID-19 can produce cardiac complications as well as long-COVID persistent symptoms. Although vaccination against COVID-19 represented a clear reduction in both mortality and ICU admissions, there is very little information on whether this was accompanied by a decrease in the prevalence of post-COVID cardiac complications. The aim of this study was to analyze the relationship between COVID-19 vaccination and the prevalence of post-COVID cardiac injury assessed by echocardiogram, and long-COVID persistent cardiac symptoms.
All patients who consulted for post-COVID evaluation 14 days after discharge from acute illness were included. Patients with heart disease were excluded. The relationship between complete vaccination scheme (at least two doses applied with 14 days or more since the last dose) and pathological echocardiographic findings, as well as the relationship of vaccination with persistent long-COVID symptoms, were evaluated by multivariate analysis, adjusting for age, sex and clinical variables that would have shown significant differences in univariate analysis.
From 1883 patients, 1070 patients (56.8%) suffered acute COVID-19 without a complete vaccination scheme. Vaccination was associated with lower prevalence of cardiac injury (1.35% versus 4.11%, adjusted OR 0.33; 95% CI 0.17-0.65, p=0.01). In addition, vaccinated group had a lower prevalence of persistent long-COVID symptoms compared to unvaccinated patients (10.7% versus 18.3%, adjusted OR 0.52; 95% CI 0.40-0.69, p<0.001).
Vaccination against COVID-19 was associated with lower post-COVID cardiac complications and symptoms, reinforcing the importance of fully vaccinating the population.
急性感染后,COVID-19 可引发心脏并发症和长 COVID 持续症状。尽管 COVID-19 疫苗接种显著降低了死亡率和 ICU 住院率,但关于 COVID-19 疫苗接种是否会降低长 COVID 后心脏并发症的发生率,目前知之甚少。本研究旨在分析 COVID-19 疫苗接种与超声心动图评估的长 COVID 后心脏损伤和长 COVID 持续心脏症状的相关性。
纳入急性疾病出院后 14 天内因长 COVID 就诊的所有患者。排除患有心脏病的患者。通过多变量分析,调整年龄、性别和单变量分析中显示有显著差异的临床变量,评估完全疫苗接种方案(至少接种两剂,最后一剂后 14 天或以上)与病理性超声心动图结果之间的关系,以及疫苗接种与持续长 COVID 症状之间的关系。
在 1883 名患者中,有 1070 名(56.8%)患者患有未经完全疫苗接种方案治疗的急性 COVID-19。疫苗接种与较低的心脏损伤发生率相关(1.35%比 4.11%,调整 OR 0.33;95%CI 0.17-0.65,p=0.01)。此外,与未接种疫苗的患者相比,接种疫苗的患者长 COVID 持续症状的发生率较低(10.7%比 18.3%,调整 OR 0.52;95%CI 0.40-0.69,p<0.001)。
COVID-19 疫苗接种与较低的长 COVID 后心脏并发症和症状相关,这强化了为人群全面接种疫苗的重要性。